Clinical Trials on HR Metastatic Breast Cancer
Total 16207 results
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
Theodoros FoukakisTerminatedBreast Cancer MetastaticSweden, United Kingdom
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
Centre Francois BaclesseActive, not recruitingBreast Cancer | Metastatic Breast CancerFrance
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
National Cancer Institute, SlovakiaWithdrawnMetastatic Breast CancerSlovakia
-
University of Michigan Rogel Cancer CenterTerminatedMetastatic Breast CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruiting
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedMetastatic Breast CancerCanada
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
Henan Cancer HospitalActive, not recruitingMetastatic Breast CancerChina
-
Consorzio OncotechActive, not recruitingMetastatic Breast CancerItaly
-
Translational Drug DevelopmentSide-Out FoundationCompletedMetastatic Breast CancerUnited States
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Breast CancerItaly
-
Hunan Cancer HospitalCompletedMetastatic Breast CancerChina
-
Universitaire Ziekenhuizen KU LeuvenPfizerCompletedMetastatic Breast CancerBelgium
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedAtezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer (Anastase)Breast Cancer MetastaticItaly
-
PfizerCompleted
-
UNICANCERNovartis; Fondation ARCCompletedMetastatic Breast CancerFrance
-
Athenex, Inc.CompletedMetastatic Breast CancerArgentina, Chile, Colombia, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Panama, Peru
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Fudan UniversityActive, not recruiting
-
Milton S. Hershey Medical CenterCompletedMetastatic Breast CancerUnited States
-
Michael Morse, MDGlaxoSmithKlineCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSamus Therapeutics, Inc.CompletedMetastatic Breast CancerUnited States
-
Alaunos TherapeuticsCompletedMetastatic Breast CancerUnited States
-
Suzhou Kintor Pharmaceutical Inc,The First Affiliated Hospital with Nanjing Medical University; Sun Yat-sen... and other collaboratorsCompletedMetastatic Breast CancerChina
-
Shannon PuhallaActive, not recruitingMetastatic Breast CancerUnited States
-
Washington University School of MedicineMerck Sharp & Dohme LLCTerminatedMetastatic Breast CancerUnited States
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
West Virginia UniversityOrtho Biotech, Inc.CompletedMetastatic Breast CancerUnited States
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
National Taiwan University HospitalNovartisUnknownMetastatic Breast CancerTaiwan
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
Shaare Zedek Medical CenterUnknownMetastatic Breast CancerIsrael
-
OBI Pharma, IncCompletedMetastatic Breast CancerUnited States, Taiwan, Korea, Republic of, China, India
-
Hope Rugo, MDSusan G. Komen Breast Cancer Foundation; PlexxikonCompletedMetastatic Breast CancerUnited States
-
Asan Medical CenterEisai Inc.; Dong-A ST Co., Ltd.; Samyang Biopharmaceuticals CorporationCompletedMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
Fox Chase Cancer CenterPfizer; National Comprehensive Cancer NetworkCompletedMetastatic Breast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; First People's Hospital of FoshanCompletedMetastatic Breast CancerChina
-
University Hospital TuebingenUnknownMetastatic Breast CancerGermany
-
Immunovative Therapies, Ltd.WithdrawnMetastatic Breast CancerUnited States
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States, Spain, Belgium, France
-
Genentech, Inc.Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Canada, China, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Spain, United Kingdom, Brazil, Guatemala, Japan, Russian Federation, Singapore, Thailand, Latvia, Argentina, Poland, Ecuador, Mexico, Croatia and more
-
CelgeneTerminated
-
CelgeneTerminated